19:30 IST
BSE
Annual Report
iSERA Lifesciences Annual Report
iSERA Lifesciences Limited has submitted its Annual Report for the financial year 2025-26. The 34th Annual General Meeting is scheduled for September 29, 2026.
iSERA Lifesciences Ltd
- Share price
- ₹143.90
- Market cap
- ₹121.0 Cr
- Revenue (annual)
- ₹1.36 Cr
- Net profit (annual)
- ₹0.26 Cr
- P/E (TTM)
- 466.5×Sector 21.8×
- Promoter holding
- 58.63%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
16:04 IST
BSE
Annual General Meeting
iSERA Lifesciences Annual General Meeting
iSERA Lifesciences has scheduled its 34th Annual General Meeting for September 29, 2026, and appointed a scrutinizer to oversee the voting process for the event.
22:49 IST
BSE
Other Announcement
iSERA Lifesciences Other Announcement
iSERA Lifesciences filed its Monitoring Agency Report for the Rights Issue proceeds utilization for the quarter ended June 30, 2026.
- Value
- ₹8.08 Cr
14:40 IST
BSE
Financial Results
iSERA Lifesciences Q1 FY27 Results: Net Loss of ₹0.3 Cr
iSERA Lifesciences Ltd reported a net loss of ₹0.3 Cr for Q1 FY27.
- Key figure
- Net loss ₹0.3 Cr